μCaler DNA Full Screen System
Pan‑cancer screening
CommercialActive
Key Facts
About Nanodigmbio
A Singapore‑based NGS diagnostics platform delivering ultra‑sensitive, rapid targeted sequencing solutions for oncology and infectious disease.
View full company profile